levoleucovorin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the levoleucovorin drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | levoleucovorin |
| SUBSTANCE NAME: | LEVOLEUCOVORIN CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-02-14 |
| END MARKETING DATE: | 0000-00-00 |
levoleucovorin HUMAN PRESCRIPTION DRUG Details:
| Item Description | levoleucovorin from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2017-02-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45963-762_b15d7780-3032-47a2-bab8-8b66db2de384 |
| PRODUCT NDC: | 45963-762 |
| APPLICATION NUMBER: | ANDA206516 |
Other LEVOLEUCOVORIN CALCIUM Pharmaceutical Manufacturers / Labelers:
